Pharmaquest: what changed
What changed
Pharmaquest
NACE 64.210, Activities of holding companies
filed annual accounts (NBB)
Net result for the year
€239,015
2024 · €80,263+€158,752
Equity
€34,187
2024 · €34,450-€263
Cash
€160,928
2024 · €91,942+€68,986
Balance sheet total
€1.5m
2024 · €1.4m+€44,444
Largest movements
Assets
- Cash +€68,986
up €68,986 (+75.0%), from €91,942 to €160,928
mainly Net result for the year (+€239,015) and Other debts (+€159,424)
- Receivables within one year -€26,084
down €26,084 (-38.4%), from €67,964 to €41,880
of which Trade receivables: -€36,300
Equity and liabilities
- Other debts +€159,424
up €159,424 (+196%), from €81,378 to €240,802
- Debts after one year -€106,653
down €106,653 (-9.1%), from €1.2m to €1.1m
Income statement
- Gross operating margin +€205,499
up €205,499 (+171%), from €120,486 to €325,985
- Taxes +€23,760
up €23,760 (+113%), from €21,096 to €44,856
- Financial charges +€23,486
up €23,486 (+127%), from €18,442 to €41,928
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€80,263
Gross operating margin
+€205,499
Depreciation
+€451
Other operating charges
+€49
Financial charges
-€23,486
Taxes
-€23,760
Result 2025
€239,015
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€414,913
Investment
€0
Financing
-€345,927
Cash 2024
€91,942
From operations (derived)
+€414,913
Net result for the year
+€239,015
Receivables within one year
+€26,084
Deferred charges and accrued income
-€1,542
Trade debts
+€484
Tax, wage and social debts
-€10,107
Other debts
+€159,424
Accrued charges and deferred income
+€1,555
Financing
-€345,927
Debts after one year
-€106,653
Current portion of long-term debt
+€4
Contributions, distributions and other
-€239,278
Cash 2025
€160,928
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,440,245 | €1,484,688 | +€44,444 | +3.1% |
| Fixed assets | 21/28 | €1,280,339 | €1,280,339 | = | 0.0% |
| Tangible fixed assets | 22/27 | €0 | - | = | |
| Furniture and vehicles | 24 | €0 | - | = | |
| Financial fixed assets | 28 | €1,280,339 | €1,280,339 | = | 0.0% |
| Current assets | 29/58 | €159,906 | €204,350 | +€44,444 | +27.8% |
| Amounts receivable within one year | 40/41 | €67,964 | €41,880 | -€26,084 | -38.4% |
| Trade receivables | 40 | €65,038 | €28,738 | -€36,300 | -55.8% |
| Other amounts receivable | 41 | €2,927 | €13,143 | +€10,216 | +349% |
| Cash at bank and in hand | 54/58 | €91,942 | €160,928 | +€68,986 | +75.0% |
| Deferred charges and accrued income | 490/1 | - | €1,542 | +€1,542 | |
| Total equity and liabilities | 10/49 | €1,440,245 | €1,484,688 | +€44,444 | +3.1% |
| Equity | 10/15 | €34,450 | €34,187 | -€263 | -0.8% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €31,187 | €31,187 | = | 0.0% |
| Distributable reserves | 133 | €31,187 | €31,187 | = | 0.0% |
| Profit (loss) carried forward | 14 | €263 | €0 | -€263 | -100% |
| Amounts payable | 17/49 | €1,405,794 | €1,450,501 | +€44,707 | +3.2% |
| Amounts payable after more than one year | 17 | €1,173,644 | €1,066,990 | -€106,653 | -9.1% |
| Financial debts | 170/4 | €1,173,644 | €1,066,990 | -€106,653 | -9.1% |
| Amounts payable within one year | 42/48 | €213,753 | €363,558 | +€149,805 | +70.1% |
| Current portion of amounts payable after more than one year | 42 | €106,695 | €106,699 | +€4 | 0.0% |
| Trade debts | 44 | €850 | €1,334 | +€484 | +56.9% |
| Suppliers | 440/4 | €850 | €1,334 | +€484 | +56.9% |
| Taxes, remuneration and social security | 45 | €24,829 | €14,722 | -€10,107 | -40.7% |
| Taxes | 450/3 | €24,829 | €14,722 | -€10,107 | -40.7% |
| Other amounts payable | 47/48 | €81,378 | €240,802 | +€159,424 | +196% |
| Accrued charges and deferred income | 492/3 | €18,398 | €19,953 | +€1,555 | +8.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €451 | €0 | -€451 | -100% |
| Other operating charges | 640/8 | €235 | €186 | -€49 | -20.8% |
| Gross operating margin | 9900 | €120,486 | €325,985 | +€205,499 | +171% |
| Operating profit (loss) | 9901 | €119,801 | €325,799 | +€205,998 | +172% |
| Financial charges | 65/66B | €18,442 | €41,928 | +€23,486 | +127% |
| Recurring financial charges | 65 | €18,442 | €41,928 | +€23,486 | +127% |
| Profit (loss) for the period before taxes | 9903 | €101,359 | €283,871 | +€182,512 | +180% |
| Income taxes | 67/77 | €21,096 | €44,856 | +€23,760 | +113% |
| Profit (loss) for the period | 9904 | €80,263 | €239,015 | +€158,752 | +198% |
| Profit (loss) for the period to be appropriated | 9905 | €80,263 | €239,015 | +€158,752 | +198% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.